vs
Side-by-side financial comparison of NovaBay Pharmaceuticals, Inc. (NBY) and Robin Energy Ltd. (RBNE). Click either name above to swap in a different company.
NovaBay Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($4.8M vs $3.6M, roughly 1.3× Robin Energy Ltd.).
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis
NextEra Energy, Inc. is an American energy company that is the world's largest electric utility holding company by market capitalization, with a valuation of over $170 billion as of Oct 2024. NextEra Energy had revenues of $24.8 billion and 16,700 employees throughout the US and Canada in 2024. It has a current generating capacity of 73 gigawatts. Its subsidiaries include Florida Power & Light (FPL), NextEra Energy Resources (NEER), XPLR Energy Partners, and NextEra Energy Services.
NBY vs RBNE — Head-to-Head
Income Statement — Q4 FY2024 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $3.6M |
| Net Profit | $-1.2M | — |
| Gross Margin | 65.2% | — |
| Operating Margin | -37.2% | 12.1% |
| Net Margin | -25.5% | — |
| Revenue YoY | 126.1% | — |
| Net Profit YoY | 70.5% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | — | $3.6M | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $2.6M | — | ||
| Q4 23 | $2.1M | — | ||
| Q3 23 | $2.5M | — | ||
| Q2 23 | $3.5M | — |
| Q2 25 | — | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-1.2M | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-3.2M | — | ||
| Q4 23 | $-4.1M | — | ||
| Q3 23 | $-1.8M | — | ||
| Q2 23 | $-2.0M | — |
| Q2 25 | — | — | ||
| Q4 24 | 65.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 66.3% | — | ||
| Q1 24 | 68.2% | — | ||
| Q4 23 | 51.5% | — | ||
| Q3 23 | 67.0% | — | ||
| Q2 23 | 49.2% | — |
| Q2 25 | — | 12.1% | ||
| Q4 24 | -37.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -67.4% | — | ||
| Q1 24 | -87.1% | — | ||
| Q4 23 | -48.0% | — | ||
| Q3 23 | -28.1% | — | ||
| Q2 23 | -29.7% | — |
| Q2 25 | — | — | ||
| Q4 24 | -25.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -66.0% | — | ||
| Q1 24 | -122.2% | — | ||
| Q4 23 | -195.5% | — | ||
| Q3 23 | -70.8% | — | ||
| Q2 23 | -57.6% | — |
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.92 | — | ||
| Q2 24 | $-1.37 | — | ||
| Q1 24 | $-29.95 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $430.0K | $39.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-129.0K | $20.5M |
| Total Assets | $3.4M | $48.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | $39.4M | ||
| Q4 24 | $430.0K | — | ||
| Q3 24 | $776.0K | — | ||
| Q2 24 | $751.0K | — | ||
| Q1 24 | $1.8M | — | ||
| Q4 23 | $2.9M | — | ||
| Q3 23 | $3.5M | — | ||
| Q2 23 | $4.4M | — |
| Q2 25 | — | $20.5M | ||
| Q4 24 | $-129.0K | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $-617.0K | — | ||
| Q1 24 | $160.0K | — | ||
| Q4 23 | $3.3M | — | ||
| Q3 23 | $7.0M | — | ||
| Q2 23 | $8.6M | — |
| Q2 25 | — | $48.6M | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $5.4M | — | ||
| Q4 23 | $9.0M | — | ||
| Q3 23 | $12.9M | — | ||
| Q2 23 | $16.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | — |
| Free Cash FlowOCF − Capex | $-1.7M | — |
| FCF MarginFCF / Revenue | -35.4% | — |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-2.4M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $-2.0M | — | ||
| Q4 23 | $-592.0K | — | ||
| Q3 23 | $-646.0K | — | ||
| Q2 23 | $-1.7M | — |
| Q2 25 | — | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-2.0M | — | ||
| Q4 23 | $-595.0K | — | ||
| Q3 23 | $-647.0K | — | ||
| Q2 23 | $-1.7M | — |
| Q2 25 | — | — | ||
| Q4 24 | -35.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -75.3% | — | ||
| Q4 23 | -28.3% | — | ||
| Q3 23 | -26.1% | — | ||
| Q2 23 | -48.3% | — |
| Q2 25 | — | 0.0% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — | ||
| Q4 23 | 0.1% | — | ||
| Q3 23 | 0.0% | — | ||
| Q2 23 | 0.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NBY
| Other | $2.4M | 51% |
| Total Product Revenue | $2.3M | 49% |
RBNE
Segment breakdown not available.
